Brian Kagen

Insider

First SEC filing: May 28, 2013 · Latest: May 28, 2013

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 5 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
March 14, 2014	MED	F	657	$27.19	$17,864	3,804 Direct	-14.73%	Disposed	-57.9% (price as of 2026-08-20)
Feb. 5, 2014	MED	A	2,000	—	—	4,000 Direct	+100.00%	Acquired	(price as of 2026-08-20)
Feb. 5, 2014	MED	A	1,875	—	—	4,461 Direct	+72.51%	Acquired	(price as of 2026-08-20)
May 23, 2013	MED	A	2,586	$28.32	$73,236	2,586 Direct	—	Acquired	-59.6% (price as of 2026-08-20)
Feb. 19, 2013	MED	A	2,000	—	—	2,000 Direct	—	Acquired	(price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Feb. 5, 2014	MED	Stock Options	Common Stock (2,000)	$26.52	Feb. 5, 2024	2,000	Acquired
Feb. 19, 2013	MED	Stock Options	Common Stock (2,000)	$24.26	Feb. 19, 2023	2,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
May 28, 2013	MED	Common Shares	2,586	Direct